213 related articles for article (PubMed ID: 10740609)
1. Utility of CD34 reactivity in evaluating focal nodular hepatocellular lesions sampled by fine needle aspiration biopsy.
Kong CS; Appenzeller M; Ferrell LD
Acta Cytol; 2000; 44(2):218-22. PubMed ID: 10740609
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
[TBL] [Abstract][Full Text] [Related]
3. Different cytokeratin and neuronal cell adhesion molecule staining patterns in focal nodular hyperplasia and hepatic adenoma and their significance.
Iyer A; Robert ME; Bifulco CB; Salem RR; Jain D
Hum Pathol; 2008 Sep; 39(9):1370-7. PubMed ID: 18602664
[TBL] [Abstract][Full Text] [Related]
4. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
DU JL; Wei LX; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352
[TBL] [Abstract][Full Text] [Related]
5. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
Swanson BJ; Yearsley MM; Marsh W; Frankel WL
Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
[TBL] [Abstract][Full Text] [Related]
6. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
7. Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions. Can they be distinguished on fine needle aspiration biopsy?
Wee A; Nilsson B
Acta Cytol; 2003; 47(1):16-26. PubMed ID: 12585026
[TBL] [Abstract][Full Text] [Related]
8. Focal nodular hyperplasia-like areas in cirrhosis.
Quaglia A; Tibballs J; Grasso A; Prasad N; Nozza P; Davies SE; Burroughs AK; Watkinson A; Dhillon AP
Histopathology; 2003 Jan; 42(1):14-21. PubMed ID: 12493020
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis.
Gouysse G; Frachon S; Hervieu V; Fiorentino M; d'Errico A; Dumortier J; Boillot O; Partensky C; Grigioni WF; Scoazec JY
J Hepatol; 2004 Aug; 41(2):259-66. PubMed ID: 15288475
[TBL] [Abstract][Full Text] [Related]
10. p53 immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma.
Ojanguren I; Ariza A; Castellà EM; Fernández-Vasalo A; Mate JL; Navas-Palacios JJ
Histopathology; 1995 Jan; 26(1):63-8. PubMed ID: 7713485
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
[TBL] [Abstract][Full Text] [Related]
12. Liver biopsy for diagnosis of presumed benign hepatocellular lesions lacking magnetic resonance imaging diagnostic features of focal nodular hyperplasia.
Sannier A; Cazejust J; Lequoy M; Cervera P; Scatton O; Rosmorduc O; Wendum D
Liver Int; 2016 Nov; 36(11):1668-1676. PubMed ID: 26969817
[TBL] [Abstract][Full Text] [Related]
13. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine-needle aspirates and thin core biopsies?
de Boer WB; Segal A; Frost FA; Sterrett GF
Cancer; 2000 Oct; 90(5):273-8. PubMed ID: 11038423
[TBL] [Abstract][Full Text] [Related]
14. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
Gottschalk-Sabag S; Ron N; Glick T
Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
[TBL] [Abstract][Full Text] [Related]
15. Biopsy diagnosis of malignant versus benign liver "nodules": new helpful markers. An update.
Stahl J; Voyvodic F
Adv Anat Pathol; 2000 Jul; 7(4):230-9. PubMed ID: 10907808
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.
Wachter DL; Kristiansen G; Soll C; Hellerbrand C; Breuhahn K; Fritzsche F; Agaimy A; Hartmann A; Riener MO
Histopathology; 2012 Jan; 60(2):278-86. PubMed ID: 22211286
[TBL] [Abstract][Full Text] [Related]
17. Copper deposition in focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Chandan VS; Shah SS; Mounajjed T; Torbenson MS; Wu TT
J Clin Pathol; 2018 Jun; 71(6):504-507. PubMed ID: 29127141
[TBL] [Abstract][Full Text] [Related]
18. [Expression of CD143 and its significance in focal nodular hyperplasia of liver].
Shi L; Jiang LL; Liu WP; Tang Y
Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):421-2. PubMed ID: 17069679
[No Abstract] [Full Text] [Related]
19. Focal nodular hyperplasia lacking some key histopathological features making the diagnosis difficult.
Lepreux S; Laurent C; Balabaud C; Bioulac-Sage P
Virchows Arch; 2002 Apr; 440(4):445-6. PubMed ID: 11956829
[No Abstract] [Full Text] [Related]
20. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens.
Choi WT; Ramachandran R; Kakar S
Hum Pathol; 2017 May; 63():1-13. PubMed ID: 28087475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
